AR004052A1 - Una composición cosmética o farmacéutica que comprende un agonista beta-adrenergico - Google Patents
Una composición cosmética o farmacéutica que comprende un agonista beta-adrenergicoInfo
- Publication number
- AR004052A1 AR004052A1 ARP960104829A ARP960104829A AR004052A1 AR 004052 A1 AR004052 A1 AR 004052A1 AR P960104829 A ARP960104829 A AR P960104829A AR P960104829 A ARP960104829 A AR P960104829A AR 004052 A1 AR004052 A1 AR 004052A1
- Authority
- AR
- Argentina
- Prior art keywords
- cosmetic
- beta
- pharmaceutical composition
- adrenergic agonist
- composition including
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Toxicology (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se refiere a la utilización de al menos un agonista beta-adrenérgico en una composición cosmética como antagonista de substancia Po para la preparación de una composición farmacéutica, más particularmente dermatológica,d estinada a tratar las alteraciones asociadas con un exceso desíntesis y/o de liberación de substancia P. La invención se refiere igualmente a una composición cosmética o farmacéutica, para uso tópico, que comprende almenos un agonistabeta-adrenérgi co y un procedimiento de tratamiento cosmético con miras a disminuir el dolor relacionado con un exceso de síntesis y/o deliberación de substancia P o disminuir el efecto irritante de una composición cosmética.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9512447A FR2740040B1 (fr) | 1995-10-23 | 1995-10-23 | Utilisation d'au moins un agoniste beta-adrenergique en tant qu'antagoniste de substance p |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR004052A1 true AR004052A1 (es) | 1998-09-30 |
Family
ID=9483809
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP960104829A AR004052A1 (es) | 1995-10-23 | 1996-10-21 | Una composición cosmética o farmacéutica que comprende un agonista beta-adrenergico |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US5958432A (es) |
| EP (1) | EP0769293B1 (es) |
| JP (1) | JP3636473B2 (es) |
| AR (1) | AR004052A1 (es) |
| BR (1) | BR9611302A (es) |
| CA (1) | CA2222311C (es) |
| DE (1) | DE69603681T2 (es) |
| DK (1) | DK0769293T3 (es) |
| FR (1) | FR2740040B1 (es) |
| HU (1) | HUP9900511A3 (es) |
| NO (1) | NO312273B1 (es) |
| PL (1) | PL186366B1 (es) |
| RU (1) | RU2169552C2 (es) |
| WO (1) | WO1997015281A1 (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5948972A (en) * | 1994-12-22 | 1999-09-07 | Kla-Tencor Corporation | Dual stage instrument for scanning a specimen |
| AU2001282988B2 (en) * | 2000-07-26 | 2006-01-05 | Atopic Pty Ltd | Methods for treating atopic disorders |
| ITPD20010187A1 (it) * | 2001-07-23 | 2003-01-23 | Cutech Srl | Trattamento del follicolo polifero, in particolare contro la caduta dei capelli |
| EP1295599A1 (en) * | 2001-09-21 | 2003-03-26 | Boehringer Ingelheim International GmbH | Method for the treatment of prevention of atopic dermatitis |
| US20030219573A1 (en) * | 2002-03-27 | 2003-11-27 | Torgny Falk | Absorbent product |
| US8343519B2 (en) * | 2003-02-19 | 2013-01-01 | L'oreal S.A. | Chemical enhancer and method |
| US20040209850A1 (en) * | 2003-04-15 | 2004-10-21 | Theraquest Biosciences, Llc | Methods of treating pain and compositions for use therefor |
| WO2006054513A1 (ja) * | 2004-11-19 | 2006-05-26 | Kissei Pharmaceutical Co., Ltd. | 神経因性疼痛の予防又は治療剤 |
| PL1719507T3 (pl) | 2005-04-13 | 2010-12-31 | Cipher Pharmaceuticals Inc | Agoniści receptora beta2-adrenergicznego do leczenia chorób tkanki łącznej skóry |
| ES2375924T3 (es) * | 2008-01-18 | 2012-03-07 | Centre National De La Recherche Scientifique - Cnrs | Agonistas beta-2 adrenérgicos para su utilización en el tratamiento de la alodinia neurop�?tica crónica. |
| GB0805535D0 (en) * | 2008-03-27 | 2008-04-30 | Univ Leicester | Scar prevention |
| US8420114B2 (en) * | 2008-04-18 | 2013-04-16 | Warsaw Orthopedic, Inc. | Alpha and beta adrenergic receptor agonists for treatment of pain and / or inflammation |
| US20120077803A1 (en) * | 2009-02-24 | 2012-03-29 | Novartis Ag | Uses Of NK Receptor Antagonists |
| GB2513297A (en) | 2013-03-08 | 2014-10-29 | Univ Leicester | Methods |
| US9937117B2 (en) | 2015-07-09 | 2018-04-10 | Galderma S.A. | Method of reducing hair loss associated with chemotherapy |
| JP7152051B2 (ja) * | 2018-05-29 | 2022-10-12 | 株式会社ナノエッグ | アトピー性皮膚炎を治療または予防するための組成物 |
| WO2020051568A1 (en) * | 2018-09-08 | 2020-03-12 | Wen Tan | NEW USE OF R-ENANTIOMER OF ADRENERGIC β2 RECEPTOR AGONISTS FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE AND ITS EXTRA INTESTINAL MANIFESTATIONS |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1474316A (en) * | 1975-02-12 | 1977-05-25 | Seperic | O-aminoalkyl oximes |
| US4038417A (en) * | 1975-06-19 | 1977-07-26 | Nelson Research & Development Company | Method for treatment of psoriasis |
| US4525359A (en) * | 1982-12-10 | 1985-06-25 | Greenway Frank L Iii | Treatment for selective weight control |
| US5366731A (en) * | 1990-08-24 | 1994-11-22 | Wisconsin Alumni Research Foundation | Cosmetic compositions containing secosterol compounds |
| IL99368A (en) * | 1991-09-02 | 1996-01-19 | Teva Pharma | Preparations for the treatment of psoriasis and atopic dermatitis, which contain the result of xanthine |
| CA2114968A1 (en) * | 1993-02-25 | 1994-08-26 | John Wille | Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity |
| JPH07258067A (ja) * | 1994-03-18 | 1995-10-09 | Kao Corp | 浴用剤組成物 |
| FR2719474B1 (fr) * | 1994-05-05 | 1996-05-31 | Oreal | Utilisation d'un antagoniste de substance P dans une composition cosmétique et composition obtenue. |
-
1995
- 1995-10-23 FR FR9512447A patent/FR2740040B1/fr not_active Expired - Fee Related
-
1996
- 1996-10-01 BR BR9611302A patent/BR9611302A/pt not_active IP Right Cessation
- 1996-10-01 EP EP96402098A patent/EP0769293B1/fr not_active Expired - Lifetime
- 1996-10-01 CA CA002222311A patent/CA2222311C/fr not_active Expired - Fee Related
- 1996-10-01 WO PCT/FR1996/001530 patent/WO1997015281A1/fr active Application Filing
- 1996-10-01 JP JP51633197A patent/JP3636473B2/ja not_active Expired - Fee Related
- 1996-10-01 DE DE69603681T patent/DE69603681T2/de not_active Expired - Fee Related
- 1996-10-01 HU HU9900511A patent/HUP9900511A3/hu unknown
- 1996-10-01 RU RU97121883/14A patent/RU2169552C2/ru not_active IP Right Cessation
- 1996-10-01 DK DK96402098T patent/DK0769293T3/da active
- 1996-10-01 PL PL96324924A patent/PL186366B1/pl not_active IP Right Cessation
- 1996-10-21 AR ARP960104829A patent/AR004052A1/es not_active Application Discontinuation
- 1996-10-23 US US08/731,967 patent/US5958432A/en not_active Expired - Fee Related
-
1997
- 1997-12-30 NO NO19976143A patent/NO312273B1/no unknown
-
1999
- 1999-05-12 US US09/310,099 patent/US6267972B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2222311A1 (fr) | 1997-05-01 |
| DE69603681D1 (de) | 1999-09-16 |
| JP3636473B2 (ja) | 2005-04-06 |
| HUP9900511A2 (hu) | 1999-07-28 |
| MX9710475A (es) | 1998-08-30 |
| BR9611302A (pt) | 1999-03-30 |
| RU2169552C2 (ru) | 2001-06-27 |
| EP0769293A2 (fr) | 1997-04-23 |
| HUP9900511A3 (en) | 2000-09-28 |
| CA2222311C (fr) | 2006-11-28 |
| DK0769293T3 (da) | 1999-12-06 |
| WO1997015281A1 (fr) | 1997-05-01 |
| US5958432A (en) | 1999-09-28 |
| PL324924A1 (en) | 1998-06-22 |
| NO312273B1 (no) | 2002-04-22 |
| JP2000503628A (ja) | 2000-03-28 |
| PL186366B1 (pl) | 2003-12-31 |
| EP0769293B1 (fr) | 1999-08-11 |
| EP0769293A3 (fr) | 1997-05-02 |
| FR2740040B1 (fr) | 1997-12-05 |
| US6267972B1 (en) | 2001-07-31 |
| NO976143D0 (no) | 1997-12-30 |
| NO976143L (no) | 1998-06-03 |
| DE69603681T2 (de) | 1999-11-25 |
| FR2740040A1 (fr) | 1997-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR004052A1 (es) | Una composición cosmética o farmacéutica que comprende un agonista beta-adrenergico | |
| AR003989A1 (es) | Composicion cosmetica o farmaceutica y procedimiento de tratamiento cosmetico, excluido tdo tratamiento terapeutico que utiliza la composicion cosmetica. | |
| ES2159382T3 (es) | Compuestos estilbenicos con grupo adamantilo, composiciones que los contienen y utilizaciones. | |
| ES2157307T3 (es) | Composicion topica que contiene un antagonista de sustancia p. | |
| MXPA02007822A (es) | Composicion cosmetica, especialmente para el uso en piel envejecida y/o tensa. | |
| ES2063073T3 (es) | Derivados de arilmetilenilo conocidos y nuevos seleccionados de tiazolidinonas, imidazolidinonas y oxazolidinonas utiles como agentes antialergicos y agentes antiinflamatorios. | |
| ES2161085T3 (es) | Formulaciones que contienen oxaliplatino. | |
| ES2081110T3 (es) | Composicion cosmetica o farmaceutica, particularmente dermatologica, destinada a favorecer la pigmentacion de la piel o de los cabellos, que contiene un extracto de cyperus y su procedimiento de fabricacion. | |
| ES2157684T3 (es) | Composicion de blanqueo de la piel y/o de los cabellos. | |
| MX9301929A (es) | Derivados de pirimidina y procedimientos para su preparacion. | |
| ECSP055609A (es) | "Uso de inhibidores de la IkB-quinasa para el tratamiento del dolor" | |
| ES2176795T3 (es) | Composiciones a base de esfingomielanasa y su utilizacion. | |
| MX9801596A (es) | Composiciones aliviadoras del prurito, cosmeticas y farmaceuticas o ambas. | |
| AR006405A1 (es) | Utilizacion de un extracto de al menos un iridacea en el tratamiento de las arrugas. | |
| AR017222A1 (es) | Procedimiento de utilizacion de un agente que inhibe el desarrollo de p.ovale, en la preparacion de medicamentos | |
| RU95103892A (ru) | Композиция топического нанесения для стимулирования роста волос и/или замедления их выпадения, способ косметического лечения волос, применение производного альфа -пирона для получения композиции | |
| HUP0100539A2 (hu) | D-vitamint és kálciumot tartalmazó gyógyászati készítmények és eljárás azok előállítására | |
| ATE259210T1 (de) | Trichologische lotion für die topische anwendung | |
| UA35611C2 (uk) | Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри | |
| PT817625E (pt) | Composicoes para o tratamento de pele fotodanificada, compreendendo um antagonista de rar-alfa e um retinoide multi-selectivo | |
| ES2174337T3 (es) | Uso topico de los agonistas opioides kappa para el tratamiento del dolor ocular. | |
| BR9814937A (pt) | Utilização de uma quantidade suficiente de pelo menos um extrato de pelo um vegetal do gênero chrysanthemum, composição cosmética ou farmacêutica e processo de tratamento cosmético. | |
| ATE237331T1 (de) | Deuterierte wirkstoffe in transdermaler applikation | |
| AR004326A1 (es) | Utilizacion de al menos un antagonista de tnf-alfa, composicion cosmetica, farmaceutica o dermatologica que contiene dicho antagonista y procedimiento detratamiento cosmetico empleando dicho antagonista. | |
| ES2136954T3 (es) | Utilizacion de al menos un agua termal de vichy como antagonista de sustancia p. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |